FULL DISCLOSURE: This is sponsored content for Cytophage Technologies. In this interview, Dr. Steven Theriault BSc, MSc, PhD, CEO of Cytophage Technologies Ltd (TSXV: CYTO), sits down with Small Cap Steve to shed light on Cytophage’s groundbreaking work in health science, specifically addressing bacterial infections through tailored bacteriophages. Bacteriophages, viruses that selectively infect and eliminate … Continue reading The Solution To Antibiotic Resistance – With Cytophage CEO Dr Steven Theriault